Literature DB >> 2008830

Segmental wall motion abnormalities in the absence of clinically documented myocardial infarction: clinical significance and evidence of hibernating myocardium.

S J Lewis1, S G Sawada, T Ryan, D S Segar, W F Armstrong, H Feigenbaum.   

Abstract

To determine the frequency and significance of left ventricular wall motion abnormalities in patients without clinical evidence of myocardial infarction, we reviewed the two-dimensional echocardiograms of 252 patients who had no history or electrocardiographic evidence of myocardial infarction and who subsequently underwent coronary angiography. Seventy-seven patients (31%) had one or more segmental wall motion abnormalities. Sixty-six of the 77 patients (86%) had significant coronary artery disease (greater than or equal to 50% luminal diameter stenosis). Seventy-four percent of the patients with coronary artery disease had multivessel disease. The left ventricle was divided into anterior and posterior regions. In the 66 patients, there were 77 separate regions with wall motion abnormalities (49 hypokinesis, 22 akinesis, 6 dyskinesis), including 60 regions (78%) supplied by coronary vessels with greater than or equal to 70% stenosis. Thirty-two patients underwent coronary artery bypass surgery or percutaneous transluminal coronary angioplasty. Follow-up echocardiograms were obtained in 19 patients who had wall motion abnormalities involving 22 regions. Twenty of the 22 regions were revascularized. Wall motion improved in 17 of 20 regions (85%) and returned to normal in 15 regions (75%). We conclude that segmental wall motion abnormalities may be detected by echocardiography in up to one third of patients evaluated for suspected coronary artery disease without documented myocardial infarction. These abnormalities are associated with a high likelihood of multivessel disease as well as with significant narrowing of the artery supplying the region demonstrating abnormal wall motion. Improvement in segmental wall motion abnormalities after revascularization suggests that these areas represent regions of hibernating myocardium.

Entities:  

Mesh:

Year:  1991        PMID: 2008830     DOI: 10.1016/0002-8703(91)90666-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

Review 1.  Hibernation and heart failure.

Authors:  P G Camici
Journal:  Heart       Date:  2004-02       Impact factor: 5.994

Review 2.  Recovery of myocardial function in the hibernating heart.

Authors:  C W Hamm
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 3.  Hibernating myocardium: a historical perspective.

Authors:  J F Tubau; S H Rahimtoola
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

Review 4.  Clinical applications of cardiovascular magnetic resonance imaging.

Authors:  Constantin B Marcu; Aernout M Beek; Albert C van Rossum
Journal:  CMAJ       Date:  2006-10-10       Impact factor: 8.262

Review 5.  Echocardiographic assessment of myocardial viability: clinical applications and future directions.

Authors:  M A Vannan; J C Tardif; N G Pandian
Journal:  Int J Card Imaging       Date:  1993

Review 6.  Myocardial viability.

Authors:  Y Birnbaum; R A Kloner
Journal:  West J Med       Date:  1996-12

7.  Incremental diagnostic value of dipyridamole echocardiography and exercise thallium 201 scintigraphy in the assessment of presence and extent of coronary artery disease.

Authors:  V Di Bello; E Gori; C R Bellina; O Parodi; N Molea; G Santoro; G Mariani; U Conti; E Magagnini; P Marzullo
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

8.  Regional myocardial velocity imaged by magnetic resonance in patients with ischaemic heart disease.

Authors:  S P Karwatowski; R H Mohiaddin; G Z Yang; D N Firmin; M St John Sutton; S R Underwood
Journal:  Br Heart J       Date:  1994-10

9.  A model combining rest-only ECG-gated SPECT myocardial perfusion imaging and cardiovascular risk factors can effectively predict obstructive coronary artery disease.

Authors:  Bao Liu; Wenji Yu; Jianfeng Wang; Xiaoliang Shao; Feifei Zhang; Mingge Zhou; Yunmei Shi; Bing Wang; Yiduo Xu; Yuetao Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-06-15       Impact factor: 2.174

10.  A comparison between brachial and echocardiographic systolic time intervals.

Authors:  Ho-Ming Su; Tsung-Hsien Lin; Po-Chao Hsu; Chun-Yuan Chu; Wen-Hsien Lee; Szu-Chia Chen; Chee-Siong Lee; Wen-Chol Voon; Wen-Ter Lai; Sheng-Hsiung Sheu
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.